Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164
NCT00650104
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
76
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Ropinirole XL (formerly CR)
Sponsor
GlaxoSmithKline